For the past two years I was involved in investigating unique metabolic phenotypes in non-small cell lung cancer and aided in the discovery of novel diagnostic and therapeutic strategies for lung squamous cell carcinoma. I am currently interested in metabolic reprogramming and the role of redox homeostasis within non-small cell lung cancer in order to identify viable therapies for a currently difficult-to-treat disease.